Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Protagonist Therapeutics, Inc | Chief Medical Officer | Common Stock | 46.4K | $1.9M | $40.98 | Nov 15, 2024 | Direct |
SUTRO BIOPHARMA, INC. | Chief Medical Officer | Common Stock | 37.7K | $178K | $4.71 | Mar 5, 2022 | Direct |
SUTRO BIOPHARMA, INC. | Chief Medical Officer | Restricted Stock Unit (RSU) | 37.5K | $176K | $4.71 | Mar 5, 2022 | Direct |
Protagonist Therapeutics, Inc | Chief Medical Officer | Stock Option (right to buy) | 97.5K | Jan 2, 2024 | Direct | ||
SUTRO BIOPHARMA, INC. | Chief Medical Officer | Stock Option (right to buy Common Stock) | 52K | Mar 4, 2022 | Direct | ||
Forma Therapeutics Holdings, Inc. | Director | Common Stock | 0 | $5.05 | Oct 14, 2022 | Direct | |
Forma Therapeutics Holdings, Inc. | Director | Stock Option (Right to Buy) | 0 | Oct 14, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PTGX | Protagonist Therapeutics, Inc | Nov 15, 2024 | 1 | -$78.1K | 4 | Nov 19, 2024 | Chief Medical Officer |
PTGX | Protagonist Therapeutics, Inc | Jan 16, 2024 | 1 | -$10.5K | 4 | Jan 18, 2024 | Chief Medical Officer |
PTGX | Protagonist Therapeutics, Inc | Nov 15, 2023 | 3 | -$30K | 4 | Jan 4, 2024 | Chief Medical Officer |
PTGX | Protagonist Therapeutics, Inc | Jan 16, 2023 | 2 | $0 | 4 | Jan 18, 2023 | Chief Medical Officer |
PTGX | Protagonist Therapeutics, Inc | Nov 15, 2022 | 2 | $0 | 4 | Nov 17, 2022 | Chief Medical Officer |
PTGX | Protagonist Therapeutics, Inc | Nov 7, 2022 | 0 | $0 | 3 | Nov 17, 2022 | Chief Medical Officer |
FMTX | Forma Therapeutics Holdings, Inc. | Oct 14, 2022 | 3 | $0 | 4 | Oct 14, 2022 | Director |
FMTX | Forma Therapeutics Holdings, Inc. | Jun 8, 2022 | 2 | $0 | 4 | Jun 9, 2022 | Director |
STRO | SUTRO BIOPHARMA, INC. | Mar 4, 2022 | 5 | -$35.6K | 4 | Mar 7, 2022 | Chief Medical Officer |
STRO | SUTRO BIOPHARMA, INC. | Jan 29, 2022 | 3 | -$22.3K | 4 | Feb 1, 2022 | Chief Medical Officer |
FMTX | Forma Therapeutics Holdings, Inc. | Jan 12, 2022 | 2 | $0 | 4 | Jan 13, 2022 | Director |
FMTX | Forma Therapeutics Holdings, Inc. | Jan 12, 2022 | 0 | $0 | 3 | Jan 13, 2022 | Director |
STRO | SUTRO BIOPHARMA, INC. | Sep 24, 2021 | 3 | -$57.2K | 4 | Sep 28, 2021 | Chief Medical Officer |